This test is most useful if any of these apply to you.
If you have ever felt your throat tingle, your skin flush, or your stomach turn after biting into a kiwi, the question is not just whether you are allergic. It is which kiwi protein your immune system is reacting to, because that answer shapes how cautious you need to be.
This test looks for antibodies your body has built against one specific kiwifruit protein called Act d 10. Knowing whether this particular protein triggers you helps clarify which kiwi allergy pattern you may have and which related plant foods could cross-react.
Kiwifruit contains at least 13 different proteins that can trigger allergic responses. Act d 10 is one of them, and it belongs to a family called nonspecific lipid transfer proteins (nsLTPs), which are small, sturdy proteins found in the skin, pulp, and seeds of many plant foods. Because they survive heat and stomach acid well, proteins in the LTP family as a class have been linked to more whole-body reactions than oral-only symptoms, though the specific clinical role of Act d 10 in driving severe kiwi reactions is not firmly established.
What this blood test measures is not the kiwi protein itself, but the IgE antibody (immunoglobulin E, the antibody class your immune system uses to flag allergens) that your immune system has built specifically against Act d 10. Detectable levels mean your body recognizes this protein as a threat and is primed to release allergic chemicals the next time it appears.
A standard kiwi allergy test uses an extract of the whole fruit, mixing all the proteins together. That approach catches some sensitization but misses a lot. In a European study of people with confirmed kiwi allergy, whole-extract blood testing caught only about 46 out of 100 cases, and a skin prick test using extract caught just 20 out of 100.
When researchers added testing for six individual kiwi proteins, including Act d 10, the diagnostic catch rate climbed to 65 out of 100. The reason is that different people react to different proteins, and lumping everything together dilutes the signal from any one of them. Component testing tells you not just whether you are sensitized, but to which specific molecule.
Sensitization to Act d 10 fits a recognizable pattern called LTP allergy. People whose immune systems react to lipid transfer proteins often cross-react to similar proteins in peaches, nuts, and peanuts, which means an Act d 10 positive result can hint at broader food allergy considerations. Importantly, in the largest European study to date, it was Act d 1 (not Act d 10) that was independently associated with severe kiwifruit reactions, so Act d 10 positivity by itself is not a reliable marker of systemic risk.
Geography matters here. In the European cohort mentioned above, Act d 10 sensitization showed up in about 22 percent of southern European kiwi-allergic patients, and profilin (Act d 9) sensitization showed up in about 31 percent. These were the two most common sensitization patterns in that region, though they represent distinct immunological pathways rather than a single combined phenotype. In other parts of Europe, Act d 10 reactivity was much less common, with people more often reacting to Act d 1 (the major kiwi allergen tied to severe reactions) or Act d 8 (a birch pollen-related protein that usually causes milder mouth symptoms).
A detectable Act d 10 IgE result means your immune system has built antibodies against the kiwi lipid transfer protein. This points toward an LTP-type allergy pattern, a category that as a class is more often associated with whole-body symptoms (hives spreading beyond the mouth, breathing trouble, drops in blood pressure) than the localized tingling seen in pollen-related kiwi allergy. The risk profile for any individual person, though, depends on the full clinical picture, not the Act d 10 result alone.
A low or undetectable Act d 10 result does not rule out kiwi allergy. Many people react through other kiwi proteins entirely, especially Act d 1, Act d 8, or the seed storage proteins Act d 12 and Act d 13. If your kiwi reactions are real but your Act d 10 is negative, your sensitization is likely driven by a different component, and a broader kiwi panel can clarify which one.
You might expect that higher antibody levels mean more dangerous reactions. The evidence does not support that simple read. Reviews of food allergy diagnostics emphasize that specific IgE levels, including to Act d 10, do not consistently track with how severe your symptoms will be or how they change with age.
The right way to think about this test is as a phenotype indicator, not a severity gauge. A positive Act d 10 tells you which family of kiwi proteins your immune system is wired to react against, which informs the type of allergy you have and which other foods might cross-react. The actual severity of any given reaction depends on the dose you eat, your background allergy burden that day, and other factors a blood test cannot capture.
Component testing works best as a panel rather than a single result. Each kiwi protein tells a different story about your immune response:
| Kiwi Component | What Sensitization Usually Signals |
|---|---|
| Act d 1 | Actinidin; the kiwi component most strongly and independently associated with severe kiwifruit reactions |
| Act d 8 | Birch pollen (Bet v 1) homolog; typically milder, mouth-only pollen-food symptoms |
| Act d 9 | Profilin; broad cross-reactivity to many plant foods but often limited clinical relevance |
| Act d 10 | Nonspecific lipid transfer protein; LTP family is broadly linked to systemic reactions, though Act d 10's specific clinical role is less established |
What this means for you: a single positive component rarely tells the full story. If you know you react to kiwi, understanding which proteins drive that reaction helps you and a clinician make smarter decisions about which related foods to be cautious of and how aggressively to carry emergency medication.
Allergen-specific IgE is not a fixed number. Levels can shift over months and years as your immune system is exposed to or avoids the trigger. Reviews of biological variation note that within-person fluctuations in many lab markers are wide enough that a single reading often misrepresents a person's typical level, and personalized reference ranges built from 3 to 5 repeated measurements give a more accurate picture.
For Act d 10, a practical cadence is to get a baseline now, retest in 6 to 12 months if you are deliberately avoiding kiwi or doing supervised exposure, and then at least annually to track whether sensitization is rising, falling, or stable. A clear downward trend over years can suggest your body is tolerating the protein better; a rising trend warrants a closer look at your wider allergy picture.
A few things can distort a single Act d 10 reading and lead you astray:
If your Act d 10 IgE is positive but you have never reacted to kiwi, do not start eating it freely or eliminate it on the test result alone. The next step is to pair this result with the rest of the kiwi component panel (Act d 1, 2, 5, 8, 9, and ideally Act d 12 and 13) and with your actual history of symptoms after eating kiwi or related foods like peach, hazelnut, or peanut.
If you have had reactions and your Act d 10 is positive, the combination fits an LTP allergy pattern and should prompt a conversation with an allergist about which cross-reactive foods to be careful of and whether to carry emergency epinephrine. If your Act d 10 is negative but you still react to kiwi, ask for component testing on Act d 1, 8, and the seed storage proteins, since one of those is likely driving your symptoms. When the picture is unclear, a supervised oral food challenge remains the gold standard for confirming or ruling out actual clinical allergy.
Kiwi (Act d 10) IgE is best interpreted alongside these tests.
Kiwi (Act d 10) IgE is included in these pre-built panels.